Insmed Inc

Common Name
Insmed
Country
United States
Sector
Healthcare
Industry
Biotechnology
Employees
1,271
Ticker
INSM
Exchange
NASDAQ/NGS
Website
insmed.com
Description
Insmed Inc. is a biopharmaceutical company dedicated to enhancing the lives of patients with rare diseases. The company's primary focus is on the development and commercialization of treatments for se...

Insmed's GHG Emissions Data Preview

In 2024, Insmed completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).

Insmed has also provided a category-level breakdown for 7 out of 15 Scope 3 emissions categories, offering greater transparency into its value chain emissions.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Market-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Location-Based
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
Copy restricted. Please purchase to unlock this data.
0000000
Download Data

Verified Sources Behind Insmed’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Insmed’s data sources below and access millions more through our Disclosure Search.

a. Insmed's Responsibility Report 2024
a. Insmed's Responsibility Report 2024
b. Insmed's Corporate Responsibility Report (CRR) 2023
b. Insmed's Corporate Responsibility Report (CRR) 2023

Insights into Insmed's Operational Emissions

In 2024, the total operational greenhouse gas (GHG) emissions of Insmed amounted to 3,701 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2023, the total operational greenhouse gas (GHG) emissions of Insmed increased by 65.89%, suggesting that the company faced challenges in reducing its emissions from its core operations. a b

Insmed's Scope 1 Emissions Over Time

2023202404509001.35 k1.8 ktCO2e+50%
  • Total Scope 1
  • Year-over-Year Change

What are Insmed's Scope 1 emissions?

In 2024, the total Scope 1 emissions of Insmed were 1,666 metric tons of CO₂ equivalent (tCO₂e). a

Compared to the previous year (2023), Insmed's Scope 1 emissions increased by 50.23%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a b

What are Insmed's Scope 2 emissions?

In 2024, Insmed reported Scope 2 greenhouse gas (GHG) emissions of 2,077 tCO₂e using the market-based method and 2,035 tCO₂e using the location-based method. a

What methodology does Insmed use for Scope 2 reporting?

In 2024, Insmed reported its Scope 2 emissions using the market-based method and using the location-based method. a

Insmed's Scope 2 Emissions Over Time

2023202405501.1 k1.65 k2.2 ktCO2e
  • Total Scope 2 Location-Based
  • Total Scope 2 Market-Based
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Insmed's Value Chain Emissions

In 2024, Insmed reported 66,779 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain. a

The 2024 disclosure of Insmed includes a breakdown across 7 of the 15 Scope 3 categories defined by the GHG Protocol, up from 0 in 2023, reflecting improved emissions accounting practices and greater transparency across the company's value chain a

Insmed's Scope 3 Emissions Over Time

2024020 k40 k60 k80 ktCO2e
  • Total Scope 3
  • Year-over-Year Change

What are Insmed's Scope 3 emissions?

In 2024, Insmed reported total Scope 3 emissions of 66,779 metric tons of CO₂ equivalent (tCO₂e). a

Approximately 100% of these emissions originated from upstream activities such as purchased goods and capital goods, while 0% came from downstream activities like product use, distribution, and end-of-life treatment. a

What categories of Scope 3 emissions does Insmed disclose?

In 2024, Insmed reported emissions for 7 out of the 15 Scope 3 categories defined by the GHG Protocol. a

This partial disclosure allows for some insight into the company's indirect impacts.

What are the main sources of Insmed's Scope 3 emissions?

In 2024, the largest contributors to Insmed's Scope 3 emissions were: a

  • Purchased Goods and Services (Cat. 1): 59,355 tCO₂e (88.88%)
  • Business Travel (Cat. 6): 2,824 tCO₂e (4.23%)
  • Employee Commuting (Cat. 7): 2,024 tCO₂e (3.03%)

Insmed's Scope 3 Emissions by Categories

Business Travel(Cat. 6)(4.2%)Purchased Goods andServices (Cat. 1)(88.9%)Employee Commuting(Cat. 7)(3.0%)

Insights into Insmed’s GHG Emissions Intensity Compared to Industry Peers

In 2024, Insmed reported Scope 1 greenhouse gas (GHG) emissions of 1,666 tCO₂e and total revenues of USD 364 millions. This translates into an emissions intensity of 4.58 tCO₂e per millions USD. a

Insmed's Scope 1 Emissions Intensity Compared to Peers

1005005,00020,000200,000Scope 1 Emissions (tCO2e)101005005,00050,000Revenues (Millions of USD)IncyteYear: 2024Scope 1: 9,576 tCO2eRevenue: $M 4,241Scope 1 Intensity: 2.26 tCO2e/$MBio-TechneYear: 2023Scope 1: 3,001 tCO2eRevenue: $M 1,137Scope 1 Intensity: 2.64 tCO2e/$MLegend BiotechYear: 2024Scope 1: 769 tCO2eRevenue: $M 627Scope 1 Intensity: 1.23 tCO2e/$MFrontage HoldingsYear: 2023Scope 1: 2,883 tCO2eRevenue: $M 2,027Scope 1 Intensity: 1.42 tCO2e/$MRegeneron PharmaceuticalsYear: 2024Scope 1: 80,300 tCO2eRevenue: $M 14,202Scope 1 Intensity: 5.65 tCO2e/$MHalozyme TherapeuticsYear: 2024Scope 1: 1,348 tCO2eRevenue: $M 1,015Scope 1 Intensity: 1.33 tCO2e/$MPrestige Consumer HealthcareYear: 2021Scope 1: 1,304 tCO2eRevenue: $M 943Scope 1 Intensity: 1.38 tCO2e/$MGuardant HealthYear: 2023Scope 1: 1,659 tCO2eRevenue: $M 564Scope 1 Intensity: 2.94 tCO2e/$MModernaYear: 2023Scope 1: 11,240 tCO2eRevenue: $M 6,754Scope 1 Intensity: 1.66 tCO2e/$MWarby ParkerYear: 2023Scope 1: 961 tCO2eRevenue: $M 670Scope 1 Intensity: 1.43 tCO2e/$MSarepta TherapeuticsYear: 2023Scope 1: 3,428 tCO2eRevenue: $M 1,243Scope 1 Intensity: 2.76 tCO2e/$MCertaraYear: 2023Scope 1: 363 tCO2eRevenue: $M 354Scope 1 Intensity: 1.03 tCO2e/$MSotera HealthYear: 2023Scope 1: 39,206 tCO2eRevenue: $M 1,049Scope 1 Intensity: 37.36 tCO2e/$MRepligenYear: 2023Scope 1: 2,236 tCO2eRevenue: $M 632Scope 1 Intensity: 3.54 tCO2e/$MCytokineticsYear: 2024Scope 1: 242 tCO2eRevenue: $M 18Scope 1 Intensity: 13.10 tCO2e/$MAlnylam PharmaceuticalsYear: 2024Scope 1: 3,832 tCO2eRevenue: $M 2,248Scope 1 Intensity: 1.70 tCO2e/$MBioMarin PharmaceuticalYear: 2022Scope 1: 14,000 tCO2eRevenue: $M 2,096Scope 1 Intensity: 6.68 tCO2e/$MIonis PharmaceuticalsYear: 2024Scope 1: 2,616 tCO2eRevenue: $M 705Scope 1 Intensity: 3.71 tCO2e/$MVertex PharmaceuticalsYear: 2024Scope 1: 8,976 tCO2eRevenue: $M 11,020Scope 1 Intensity: 0.81 tCO2e/$MInsmedYear: 2024Scope 1: 1,666 tCO2eRevenue: $M 364Scope 1 Intensity: 4.58 tCO2e/$M

How does Insmed's GHG emissions intensity compare to its peers?

In 2024, Insmed reported a Scope 1 emissions intensity of 4.58 tCO₂e per millions USD. Compared to the peer group median of 2.26 , this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors. a

Where does Insmed rank on GHG emissions intensity within its industry?

In 2024, Insmed ranked 16 out of 19 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

This places Insmed among the least efficient performers, with one of the highest emissions intensities in its sector. a

Insights into Insmed's Total Carbon Footprint

In 2024, Insmed reported a total carbon footprint of 70,480 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 3,059.12% increase compared to 2023, suggesting a rise in emissions across its operations or value chain. a b

The largest contributor to Insmed's total carbon footprint was Scope 3 emissions, accounting for 94.75% of the company's total carbon footprint, followed by Scope 2 emissions at 2.89%. a

Want Full Access to Insmed's GHG Emissions Dataset?
Sign Up